Huntington Bancshares (HBAN) PT Raised to $17 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HBAN Hot Sheet
Price: $16.01 --0%
Rating Summary:
18 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 14 | New: 9
Rating Summary:
18 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 14 | New: 9
Join SI Premium – FREE
Raymond James analyst David Long raised the price target on Huntington Bancshares (NASDAQ: HBAN) to $17.00 (from $16.00) while maintaining a Strong Buy rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $94 at Oppenheimer
- Syndax Pharmaceuticals (SNDX) PT Lowered to $36 at H.C. Wainwright
- Clorox (CLX) PT Raised to $90 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
